CN108635493A - Antitumor and cirsoid pharmaceutical composition for the treatment of and its preparation method and application - Google Patents

Antitumor and cirsoid pharmaceutical composition for the treatment of and its preparation method and application Download PDF

Info

Publication number
CN108635493A
CN108635493A CN201810937170.0A CN201810937170A CN108635493A CN 108635493 A CN108635493 A CN 108635493A CN 201810937170 A CN201810937170 A CN 201810937170A CN 108635493 A CN108635493 A CN 108635493A
Authority
CN
China
Prior art keywords
parts
pharmaceutical composition
present
treatment
antitumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810937170.0A
Other languages
Chinese (zh)
Inventor
马贵周
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810937170.0A priority Critical patent/CN108635493A/en
Publication of CN108635493A publication Critical patent/CN108635493A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/20—Aceraceae (Maple family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a kind of antitumor and cirsoid pharmaceutical compositions for the treatment of and its preparation method and application, belong to tcm field.The pharmaceutical composition is made of the raw material of following parts by weight：10 50 parts of nine bursts of longan, 10 100 parts of ox, 10 50 parts of dandelion, 5 50 parts of Rhizoma Chuanxiong, 10 50 parts of bush, 10 50 parts of Radix Astragali, 10 50 parts of paris polyphylla and lopseed.Pharmaceutical composition provided by the invention has righting reinforcing and immune function facilitation, can reduce tumor patient pain, extend life cycle, and through long-term experiment studies have shown that effect of the present invention is better than other antitumor medicine compositions.Brain tumor is tested and clinical test proves that the pharmaceutical composition of the present invention has excellent therapeutic effect to rat pituitary tumor model, curative for effect reliable.The present invention is safe, has no toxic side effect.

Description

Antitumor and cirsoid pharmaceutical composition for the treatment of and its preparation method and application
Technical field
The present invention relates to a kind of pharmaceutical composition, especially a kind of cirsoid pharmaceutical composition of antineoplaston, also Relate to and its preparation method and application, belong to tcm field.
Background technology
The cancer of early stage generally selects operative treatment, but postoperative the problem of still suffering from recurrence and transfer.And middle and advanced stage The primary treatments of cancer are still based on chemotherapy at present.
Breast cancer is one of the most common malignant tumors in women, and according to statistics, incidence accounts for the various malignant tumours of whole body 7-10%, be only second to uterine cancer in women, its morbidity it is often related with heredity and 40-60 Sui between, before and after menopause Women's incidence is higher.Usually it is happened at the malignant tumour of breast galandular epithelium tissue.It is that one kind seriously affecting women's physical and mental health Even one of the most common malignant tumour of threat to life.
In recent years, intracranial tumors incidence is in rising trend, and according to statistics, intracranial tumors account for about the 5% of general tumour, account for The 70% of virgin tumour, and other malignant tumours finally have 20-30% and are transferred to encephalic, due to the infiltrative growth of its expansion, Encephalic is when according to certain space, no matter its property is benign or pernicious, certainly will all intracranial pressure be made to increase, and oppresses brain tissue, Cause nervous centralis to damage, jeopardizes patient vitals.
The treatment of Pituitary adenoma includes mainly three kinds of operation, drug and radiotherapy therapies.Just because of no one Kind method can achieve the purpose that cure each hypophysoma completely, so various therapies cut both ways.About radiotherapy, by Belong to adenoma in hypophysoma, itself is poor to the sensibility of radiotherapy, and nearly pituitary function occur low by the patient of 70-80% after radiotherapy Subtract, reduce the quality of life of patient, operation is remaining, is not resistant to operation, is insensitive to drug, having so radiotherapy is only applicable to Suffering from the disease altogether can not undergo surgery or the patient of drug therapy.
The drug for clinically treating all kinds of tumours at present mainly has chemicals, but since chemotherapeutics toxicity is big, is killing Also human autoimmunes' cell such as kill leucocyte, lymphocyte of non-selectivity while dead tumour cell, causes patient normal Often due to being complicated by infection because of autoimmunity inferior capabilities, patient uses erious adverse reaction, and the course for the treatment of is long, costly, makes in clinic There is larger limitation in.
Traditional Chinese medicine has unique advantage in terms for the treatment of tumour, has poison is secondary to make by the natural class drug of representative of Chinese medicine With the features such as small, action target spot is various, tolerance is good, more and more it is taken seriously in terms for the treatment of tumour.Chinese medicine thinks, tumour Formation is that for rule, disorderly, channels and collaterals are obstructed qi and blood fortune, and qi and blood pent-up is formed in a certain position, and corporal parts will appear. But the anti-breast cancer Chinese medicine compound prescription dosage reported at present is larger, impurity component is more, curative effect unobvious.
Varication refers to due to factors such as hypostasis, vein tube wall weaknesses, and caused vein is tortuous, expands.Body Varicose can occur for the vein at multiple positions, for example hemorrhoid are exactly a kind of varication in fact, clinical visible also gastric and esophageal Bottom varication, varicocele and subcutaneous varicos vein of abdominal wall etc..The position that varication occurs most frequently is in lower limb.It is worth strong It adjusts, varication itself may be the secondary manifestation of other lesions, such as vena cave occlusion, answer positive treatment protopathy.
Treatment varication mostly uses operative treatment at present, that is, makees venous stripping.If operation cannot be by the quiet of varicose Arteries and veins all strips off, and the intravenous of the varicose left can make wall of vein generate aseptic inflammation with injection of sclerosing agent, mutually viscous to wall It, no longer varicose.Through clinical practice for many years, can also be recurred after many patient's operations, uncertain therapeutic efficacy is cut, and Repeated Operation also fails to control More.Modus operandi not only has patient certain pain, but also costly, and cure rate is very low.
Chinese medicine thinks that varication is because of native endowment deficiency, and tendon and vessel is weak, and long row is stood long in addition, overworked, into one Step damage tendon and vessel, so that passages through which vital energy circulates does not conform to, QI-blood circulation is unsmooth, and blood is stopped up under, and the expansion of congestion blood block train of thought is full, with the passing of time interleaved discs Qu Ercheng.With the passing of time similar to the shape of knurl.Also have because after long journey, fatigue, paddling and drenching with rain, by cold-dampness, Han Ningxuemai, stasis muscle Train of thought road and form varication.The advantage that traditional Chinese medicine is played a role with its multipath, too many levels, multiple target point is widely used in each Kind disease treatment.It was mostly controlled in the past with heat-clearing and damp-drying drug for cirsoid Chinese traditional treatment, and ignored cool blood, promoting blood circulation, detoxifies it It treats, therefore therapeutic effect is poor.
In addition, existing Chinese medicine also tends to be to have the effect of single, therefore, it is good to research and develop a kind of antitumous effect, Dosage is few, and has no toxic side effect, while can treat cirsoid pharmaceutical composition and be of great significance.
Invention content
In order to solve the above technical problem, the present invention provides a kind of antitumor and cirsoid pharmaceutical composition for the treatment of and Preparation method and application, the Chinese medicine can not only anti-cancer and detumescence, also have effects that treat varication.The specific side of the present invention Case is as follows：
A kind of antitumor and cirsoid pharmaceutical composition for the treatment of, is made of the raw material of following parts by weight：
10-100 parts of ox of nine bursts of longan, 10-50 parts of dandelion, 5-50 parts of Rhizoma Chuanxiong, 10-50 parts of bush, 10-50 parts of Radix Astragali, Yunnan weight Building 10-50 parts and 10-50 parts of lopseed.
Further, it is made of the raw material of following parts by weight：Nine bursts of longan, 50 parts of ox, 25 parts of dandelion, 20 parts of Rhizoma Chuanxiong, 30 parts of 30 parts of bush, 30 parts of Radix Astragali, 40 parts of paris polyphylla and lopseed.
The preparation method of pharmaceutical composition of the present invention, includes the following steps：Raw material is weighed in parts by weight, is mixed Uniformly, it water cover is added crosses medicinal material surface and impregnate 5-30 minutes, boiled 5-30 minutes to get to described pharmaceutical composition.
Further, dosage is daily 2-3 times, each 100ml-500ml.
Further, described pharmaceutical composition is combined with pharmaceutically acceptable carrier be prepared into oral solution, granule, The drug of capsule or Tabules.
Application of the pharmaceutical composition of the present invention in preparing tumor.
Chinese medicine composition provided by the invention screens prescription, Fang Zhong according to traditional Chinese medical theory dialectical treatmert：
Nine bursts of oxen of longan, property is sweet, bitter, warm, synthetism myogenic, stasis-dispelling and pain-killing.Fracture is controlled, traumatic injury, rheumatic arthritis, menstruation is not It adjusts, carbuncle furuncle poison is swollen, scrofula.
Dandelion, bitter sweet are trembled with fear；Enter liver, stomach；It is clearing heat and detoxicating, diuresis dissipating bind.Control acute mastitis, adenolymphitis, scrofula Scrofula, boil poisonous soreness, acute conjunctivitis, cold, fever, acute tonsillitis, acute bronchitis, gastritis, hepatitis, cholecystitis, urine Road feel contaminates.
Rhizoma Chuanxiong, it is acrid in flavour and warm in nature；Promote breath and open depression, method wind-dryness is wet, promoting blood circulation and stopping pain.It is dizzy to control air-cooled headache rotation, hypochondriac pain abdomen pain, arthritis muscle Contraction, Amenorrhea, difficult labour, postpartum stasis block pain, ulcer sores.For irregular menstruation, closed dysmenorrhea, lump in the abdomen abdominal pain, chest side of body shouting pain falls and flutters Swelling and pain, headache, arthralgia pain due to rheumatism.
Bush, it is sweet；It is salty；Xin Liang；The thoughts of returning home, liver, stomach, the spleen channel；Promoting blood circulation, detumescence ding-tong, such as married woman's amenorrhea due to stagnation of blood, pain Through, postpartum stasis pain in the chest and abdomen, postpartum anemic fainting, carbuncle swells, traumatic injury, lockjaw.
Radix Astragali, sweet, tepor；Return lung, spleen, liver and kidney channel；
Paris polyphylla has the effect of clearing heat and detoxicating, swelling and pain relieving, cool liver arresting convulsion, for carbuncle swells, abscess of throat, venomous snake bite, bruise The diseases such as the pain of injury, convulsion.
Lopseed, sweet, acrid, warm；Enter lung, liver two passes through；Cure mainly dispelling wind and eliminating dampness, the product pungent-warm, it is pungent can manage it is scattered, temperature overcome the coldness it is wet, Relaxing tendons and activating collaterals, promoting blood circulation and stopping pain, solution poison rash.
Wherein, the cooperation of nine bursts of oxen, dandelion, Radix Astragali, Rhizoma Chuanxiong, bushes of longan according to the above ratio is antitumor, especially right Brain tumor, breast cancer have notable curative effect, have certain curative effect to kidney failure.
The cooperation of longan nine bursts of oxen, Radix Astragali, paris polyphylla, lopseeds according to the above ratio has certain curative effect to varication.
Compared with prior art, beneficial effects of the present invention are as follows：
（1）Pharmaceutical composition provided by the invention has righting reinforcing and immune function facilitation, can promote tumor necrosis factor The generation of sub (INF) plays multiple target point, and multiple organ treats the effect of tumour, can reduce tumor patient pain, extend life cycle, And through long-term experiment studies have shown that effect of the present invention is better than other antitumor medicine compositions.
（2）Brain tumor is tested and clinical test proves pharmaceutical composition of the invention to rat pituitary tumor model with excellent Therapeutic effect, it is curative for effect reliable.
（3）The present invention is safe, has no toxic side effect.
Specific implementation mode
It is clearly and completely described below in conjunction with the technical solution in embodiment, it is clear that described embodiment is only Only it is rather than whole example to a part of example of the present invention.Based on the embodiments of the present invention, ordinary skill people The every other embodiment that member is obtained under the premise of not making the creative labor, shall fall within the protection scope of the present invention.
Embodiment 1
The treatment tumour of the present embodiment treats mastadenoma, cirsoid pharmaceutical composition is treated, by the original of following parts by weight Material is made：
Nine bursts of longan, 50 parts of ox, 25 parts of dandelion, 20 parts of Rhizoma Chuanxiong, 30 parts of bush, 30 parts of Radix Astragali, 40 parts of paris polyphylla and lopseed 30 Part.
Weigh raw material in parts by weight, be uniformly mixed, be added water cover cross medicinal material surface impregnate 10 minutes, boiled 8 minutes, i.e., Obtain described pharmaceutical composition.
Embodiment 2
The antitumor and cirsoid pharmaceutical composition for the treatment of of the present embodiment, is made of the raw material of following parts by weight：
Nine bursts of longan, 20 parts of ox, 10 parts of dandelion, 42 parts of Rhizoma Chuanxiong, 40 parts of bush, 35 parts of Radix Astragali, 15 parts of paris polyphylla and lopseed 20 Part.
Weigh raw material in parts by weight, be uniformly mixed, be added water cover cross medicinal material surface impregnate 20 minutes, boiled 15 minutes, Obtain described pharmaceutical composition.Diluent lactose is added in aforementioned pharmaceutical compositions or cornstarch is uniformly mixed, whole grain, It is dry, granule is made.
Embodiment 3
The antitumor and cirsoid pharmaceutical composition for the treatment of of the present embodiment, is made of the raw material of following parts by weight：
Nine bursts of longan, 90 parts of ox, 20 parts of dandelion, 20 parts of Rhizoma Chuanxiong, 20 parts of bush, 15 parts of Radix Astragali, 20 parts of paris polyphylla and lopseed 40 Part.
Weigh raw material in parts by weight, be uniformly mixed, be added water cover cross medicinal material surface impregnate 10 minutes, boiled 20 minutes, Obtain described pharmaceutical composition.Aforementioned pharmaceutical compositions are processed into pulvis by existing method.
Embodiment 4
The antitumor and cirsoid pharmaceutical composition for the treatment of of the present embodiment, is made of the raw material of following parts by weight：
Nine bursts of longan, 70 parts of ox, 35 parts of dandelion, 30 parts of Rhizoma Chuanxiong, 20 parts of bush, 30 parts of Radix Astragali, 30 parts of paris polyphylla and lopseed 25 Part.
Weigh raw material in parts by weight, be uniformly mixed, be added water cover cross medicinal material surface impregnate 30 minutes, boiled 15 minutes, Obtain described pharmaceutical composition.Aforementioned pharmaceutical compositions are processed into capsule by existing method.
5 Clinic Case of embodiment
45 years old male's brain tumor patients with terminal, take the drug of embodiment 1,2-3 times daily, each 500ml is good after taking 3 months Turn, does not recur.
50 years old Female breast cancer patients, take the drug of embodiment 1,2-3 times daily, each 200ml, after taking two weeks It improves, does not recur.
70 years old male's varicose vein patients, take the drug of embodiment 3,2-3 times daily, each 250g baths, 3 months Left and right recovery from illness, does not recur.
55 years old male's varicose vein patients, take the drug of embodiment 4,2-3 times daily, 3 tablets each time, fully recover from an illness within 3 months or so More, it does not recur.
6 anti-breast cancer pharmacological evaluation of embodiment
（1）, to the inhibiting effect of human breast carcinoma in nude mouse (MCF-7) cell
Experimental method：MCF-7 Human Breast Cancer Cells suspension is prepared, cell concentration is adjusted, armpit inoculates human milk gland before every mouse right side Cancer MC F-7 cells 5 × 106A/0 .2ml is inoculated with 20 altogether, is randomly divided into treatment group's (having of providing of the embodiment of the present invention 1 The Traditional Chinese medicine compound composition of anti-breast cancer activity, 001. gastric infusion of lot number, 2g/kg) and blank group (waiting capacity physiological saline), It after every group 10,24 hours, starts medication, once a day, continuous 24 days, after drug withdrawal, puts to death animal, observe tumour growth situation And take tumor tissue and weigh, specific experiment the results are shown in Table 1.
Inhibiting effect of the table 1 to human breast carcinoma in nude mouse (MCF-7) cell
（2）, the test of external anti-breast cancer activity
Cell strain：Human breast carcinoma (MCF-7) cell；96 orifice plates are purchased from Costar companies；RMPI1640 culture mediums are public purchased from Gibco Department；DMEM culture mediums are purchased from Gibco companies；Newborn bovine serum is purchased from Hangzhou Chinese holly company；Tetrazolium bromide (MTT) and DMSO are purchased from Amresco companies.
Used laboratory apparatus is as follows：
Laboratory apparatus：Superclean bench (Suzhou purifies model SW-CJ-IFD), CO2 incubators (SANYO models：XD-101), Microplate reader BIO-RAD (Model NO .550Serial NO.16971).
Used experimental method is as follows：
Experimental method：External anti-human mammary gland is carried out to the Chinese medicine composition that the embodiment of the present invention 1 is prepared using improvement mtt assay Cancer cell is tested：Human breast carcinoma (MCF-7) is digested with pancreatin, counts, be made a concentration of 5 × 104The cell of a/ml is outstanding Liquid.100 μ l cell suspensions will be added in 96 orifice plates per hole (per hole 5 × 103A cell), 37 DEG C are subsequently placed in, 5%CO2Incubator Middle culture 24 hours；Drug is diluted to required different gradient concentrations with non-fully culture medium, and 100 μ L are added per hole and contain accordingly Medicine culture medium, while negative control group is set up, vehicle control group and positive controls, then 96 orifice plates are placed in 37 DEG C, 5%CO2 It is cultivated 72 hours in incubator.Then 20 μ L MTT (5mg/ml) are added per hole, continue culture 4 hours, terminates culture, discards training Base is supported, is added 150 μ L DMSO dissolvings per hole, the gently mixing of shaking table 10 minutes.Enzyme is used under λ=4570nm, two wavelength of 620nm Absorbance, that is, OD value of the mark instrument detection per hole calculates the suppression of each drug using the average value of each multiple holes as the OD values of this group of cell Rate processed.
Experimental result shows the Chinese medicine composition that is prepared of the embodiment of the present invention 1, to human breast carcinoma (MCF-7) have compared with Strong inhibiting effect, each dosage group present preferable dose-effect relationship.Experimental result is as shown in table 2.
Inhibiting effect result of the table 2 to human breast carcinoma (MCF-7)
By above the experimental results showed that：Relative to conventional pharmaceutical composition（Inhibiting rate is in 50%-60%）, tool provided by the invention There is the Chinese medicine composition of anti-human mammary gland cancer activity to be significantly inhibited to being transplanted in human breast carcinoma nude mouse, also has in vitro Play the role of that human breast cancer cell is obviously inhibited to grow.Show the Chinese traditional medicine composition provided by the invention with anti-human mammary gland cancer activity Object has the function of significant anti-human breast cancer, can be used for the treatment of breast cancer disease.
Embodiment 7 inhibits brain tumor experiment
Prepare Wistar rats 120, be randomly divided into blank group, control group and embodiment 1-10 groups, often gives 10.Except sky White group is outer, is all made of estrogen method and prepares Pituitary adenoma model.Meanwhile blank group and control group give physiological saline, and implement Example 1-4 groups give the pharmaceutical preparation prepared in 1-4 of the embodiment of the present invention respectively.Rat is put to death after two weeks, takes out hypophysis, weighs weight Amount.
The result shows that the pituitary average weight of control rats is 3.6 times of blank group, show modeling success；Implement Average weight is respectively less than 2.8 times of blank group in the group of example 1-4 group rat pituitaries.There is significant difference between group.Illustrate this Invention preparation has excellent therapeutic effect to rat pituitary tumor model.
8 toxicity of embodiment is verified
50 healthy mices, weight 80-120g are selected to be randomly divided into 5 groups, every group of half male and half female, respectively with the medicine of embodiment 1-4 Preparation made of compositions is administered, and ejection preparation per injection amount is 0.2mL/10g, oral preparation gastric infusion 0.4ml/10g, once in the morning and once at night.After administration 7 days, the mouse of embodiment 1-4 there are no any Novel presentation, and diet is movable good Good, none is dead.Show within the scope of the prescription of the present invention, drug safety.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all essences in the present invention With within principle, any modification, equivalent replacement, improvement and so on should all be included in the protection scope of the present invention god.

Claims (6)

1. a kind of antitumor and cirsoid pharmaceutical composition for the treatment of, it is characterised in that：By the raw material system of following parts by weight At：
10-100 parts of ox of nine bursts of longan, 10-50 parts of dandelion, 5-50 parts of Rhizoma Chuanxiong, 10-50 parts of bush, 10-50 parts of Radix Astragali, Yunnan weight Building 10-50 parts and 10-50 parts of lopseed.
2. pharmaceutical composition according to claim 1, it is characterised in that：It is made of the raw material of following parts by weight：Longan 30 parts of nine bursts of 50 parts of oxen, 25 parts of dandelion, 20 parts of Rhizoma Chuanxiong, 30 parts of bush, 30 parts of Radix Astragali, 40 parts of paris polyphylla and lopseed.
3. the preparation method of pharmaceutical composition as claimed in claim 1 or 2, it is characterised in that：Include the following steps：By weight Number weighs raw material, is uniformly mixed, and water cover is added crosses medicinal material surface and impregnate 5-30 minutes, boiled 5-30 minutes to get to described Pharmaceutical composition.
4. the preparation method of pharmaceutical composition according to claim 3, it is characterised in that：Dosage is to take 2-3 daily It is secondary, each 100ml-500ml.
5. the preparation method of the pharmaceutical composition described in claim 3, it is characterised in that：By described pharmaceutical composition and pharmaceutically Acceptable carrier combination is prepared into the drug of oral solution, granule, capsule or Tabules.
6. application of the pharmaceutical composition in preparing antitumor or treatment varication drug described in one of claim 1-3.
CN201810937170.0A 2018-08-16 2018-08-16 Antitumor and cirsoid pharmaceutical composition for the treatment of and its preparation method and application Pending CN108635493A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810937170.0A CN108635493A (en) 2018-08-16 2018-08-16 Antitumor and cirsoid pharmaceutical composition for the treatment of and its preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810937170.0A CN108635493A (en) 2018-08-16 2018-08-16 Antitumor and cirsoid pharmaceutical composition for the treatment of and its preparation method and application

Publications (1)

Publication Number Publication Date
CN108635493A true CN108635493A (en) 2018-10-12

Family

ID=63760963

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810937170.0A Pending CN108635493A (en) 2018-08-16 2018-08-16 Antitumor and cirsoid pharmaceutical composition for the treatment of and its preparation method and application

Country Status (1)

Country Link
CN (1) CN108635493A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114404486A (en) * 2021-12-24 2022-04-29 张军卫 Decoction for treating tumor and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1376497A (en) * 2002-03-04 2002-10-30 汪贵昌 Qizhen capsule and its preparing process
CN101156639A (en) * 2007-11-23 2008-04-09 张禄 Health-care anticancer tea and its preparing process
CN103169781A (en) * 2013-03-12 2013-06-26 翁捷 Pharmaceutical composition for treating brain tumor
CN104840716A (en) * 2015-05-18 2015-08-19 南京中医药大学 Traditional Chinese medicine composition capable of resisting breast cancer activity and preparation method and application thereof
CN106421383A (en) * 2016-09-28 2017-02-22 贵州顺康信和肿瘤药物研究有限公司 Anticancer traditional Chinese medicine composition
CN106943516A (en) * 2017-04-10 2017-07-14 牡丹江医学院 A kind of antineoplastic Chinese medicine composition of internal medicine and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1376497A (en) * 2002-03-04 2002-10-30 汪贵昌 Qizhen capsule and its preparing process
CN101156639A (en) * 2007-11-23 2008-04-09 张禄 Health-care anticancer tea and its preparing process
CN103169781A (en) * 2013-03-12 2013-06-26 翁捷 Pharmaceutical composition for treating brain tumor
CN104840716A (en) * 2015-05-18 2015-08-19 南京中医药大学 Traditional Chinese medicine composition capable of resisting breast cancer activity and preparation method and application thereof
CN106421383A (en) * 2016-09-28 2017-02-22 贵州顺康信和肿瘤药物研究有限公司 Anticancer traditional Chinese medicine composition
CN106943516A (en) * 2017-04-10 2017-07-14 牡丹江医学院 A kind of antineoplastic Chinese medicine composition of internal medicine and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
曾莉: "《外科疾病处方快捷通》", 31 December 2012 *
汪贵昌等: "芪珍胶囊的实验研究", 《首都医药》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114404486A (en) * 2021-12-24 2022-04-29 张军卫 Decoction for treating tumor and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103861079B (en) Traditional Chinese medicine composition with effects of clearing heat, relieving pain and eliminating tumors
CN104383132B (en) Traditional Chinese medicine preparation used for treating gastric ulcer and preparation method
CN102772781A (en) Traditional Chinese medicine preparation for treating chronic colitis and preparation method thereof
CN115040602A (en) Pharmaceutical composition for improving hyperplasia of mammary glands and preparation method thereof
CN105535495B (en) A kind of Chinese medicine composition and preparation method of the element culturing fixed folder treatment cancer of the esophagus
CN108635493A (en) Antitumor and cirsoid pharmaceutical composition for the treatment of and its preparation method and application
CN103212031A (en) Traditional Chinese medicine composition for treating primary nephrotic syndrome and preparation method thereof
CN102940808A (en) Prescription medicine for treating lung cancer and preparation method
CN104983764A (en) Application of Babaodan in preparation of drugs for treating pulmonary fibrosis
CN108904714B (en) Preparation method of traditional Chinese medicine for treating cardiovascular diseases
CN108904713B (en) Chinese medicine for treating cardiovascular disease
CN102872362A (en) Traditional Chinese medicine for treating chronic cholecystitis
CN103169838B (en) Medicine for treating hepatitis B
CN102120022B (en) Medicament for treating pain and fever caused by cancer
CN104825922A (en) Traditional Chinese medicine composition with anti-colorectal cancer activity and preparation method and application of traditional Chinese medicine composition
CN104840716B (en) Traditional Chinese medicine compound composition with anti-breast cancer activity and its preparation method and application
CN107854685A (en) A kind of Chinese medicine composition with antitumor action and its production and use
CN103690902B (en) For preventing the Chinese medicine preparation of nasopharyngeal carcinoma radiation side reaction
CN107913402A (en) A kind of combination of Chinese tradiational and Western medicine medicine for treating atrophic gastritis and preparation method
CN104689260B (en) It is a kind of to treat breast cancer and the Chinese medicine preparation of endocrinotherapy for breast cancer side effect be improved
CN104840747A (en) Traditional Chinese medicine composition capable of resisting thyroid cancer activity and preparation method and application thereof
CN103316299B (en) Chinese medicine composition for treating primary liver cancer
CN110464774A (en) A kind of compound hydrochloric acid Propranolol oral solution for treating infantile hemangioma
CN109125489A (en) A kind of pharmaceutical composition and its preparation method and application for treating tumour and leukaemia
CN103623156B (en) One treats hypertensive Chinese medicine composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20181012